A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children

HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease

NCT03240731 ·Status: COMPLETED ·Phase: PHASE2

Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease

NCT00459225 ·Status: WITHDRAWN ·Phase: NA

Haploidentical Hematopoietic Stem Cell Transplantation

NCT02165007 ·Status: COMPLETED ·Phase: PHASE1

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

NCT00395993 ·Status: COMPLETED ·Phase: PHASE3

An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old

NCT01724138 ·Status: WITHDRAWN ·Phase: PHASE4

PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions

NCT02087553 ·Status: COMPLETED

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

NCT04968379 ·Status: WITHDRAWN ·Phase: PHASE2

Hydroxyurea and Transfusion

NCT03644953 ·Status: COMPLETED ·Phase: PHASE2

Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia

NCT01984554 ·Status: COMPLETED

The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia

NCT05214105 ·Status: RECRUITING

A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA

NCT02410213 ·Status: COMPLETED ·Phase: PHASE2

T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients

NCT00520559 ·Status: COMPLETED

Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia

NCT01461590 ·Status: COMPLETED ·Phase: PHASE2

Iron Therapy in Erythropoietic Protoporphyria

NCT05572125 ·Status: COMPLETED

Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease

NCT00305175 ·Status: COMPLETED

A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major

NCT06465550 ·Status: RECRUITING ·Phase: PHASE1

Allogeneic Genoidentical Stem Cell Transplantation in Children With Sickle-cell Anemia and Cerebral Vasculopathy

NCT01340404 ·Status: COMPLETED ·Phase: NA

Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants

NCT03359447 ·Status: UNKNOWN ·Phase: PHASE4

Eltrombopag for People With Fanconi Anemia

NCT03206086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

NCT00171210 ·Status: COMPLETED ·Phase: PHASE3

The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias

NCT01409967 ·Status: COMPLETED

A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge

NCT04920045 ·Status: TERMINATED ·Phase: NA

Iron Mediated Vascular Disease in Sickle Cell Anemia Patients

NCT01239901 ·Status: COMPLETED

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

NCT00000595 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy

NCT04437771 ·Status: ACTIVE_NOT_RECRUITING